Filing Flows › Co-Diagnostics (CODX) › Who owns the stock
Who owns Co-Diagnostics (CODX) stock
23 funds reported Co-Diagnostics (CODX) shares in their latest 13F filings, worth $1.8M in all. The largest holder is Armistice Capital, LLC ($732K). Last quarter 17 funds added to their stakes and 3 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Armistice Capital, LLC | 236,000 | $732K | new | 2026-06-30 |
| Jane Street Group, LLC | 89,240 | $277K | new | 2026-06-30 |
| Vanguard Capital Management LLC | 58,275 | $181K | new | 2026-06-30 |
| Private Advisory Group LLC | 39,387 | $122K | decrease | 2026-06-30 |
| Millennium Management LLC | 31,995 | $99K | new | 2026-06-30 |
| Susquehanna International Group, LLP | 31,239 | $97K | new | 2026-06-30 |
| Geode Capital Management, LLC | 25,575 | $79K | new | 2026-06-30 |
| Vanguard Fiduciary Trust | 19,776 | $61K | increase | 2026-06-30 |
| Virtu Financial LLC | 17,612 | $55K | new | 2026-06-30 |
| UBS Group AG | 16,091 | $50K | increase | 2026-06-30 |
| State Street | 14,800 | $46K | new | 2026-06-30 |
| Renaissance Technologies LLC | 12,500 | $39K | new | 2026-06-30 |
| Morgan Stanley | 2,877 | $9K | increase | 2026-06-30 |
| Smartleaf Asset Management LLC | 133 | $396 | unchanged | 2026-06-30 |
| Global Retirement Partners, LLC | 100 | $310 | new | 2026-06-30 |
Co-Diagnostics' latest quarter
Co-Diagnostics, Q2 2026: revenue $166K (+2% year over year), net loss $6.3M, operating cash flow −$7.2M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most CODX stock?
By the latest 13F filings: Armistice Capital, LLC ($732K); Jane Street Group, LLC ($277K); Vanguard Capital Management LLC ($181K); Private Advisory Group LLC ($122K); Millennium Management LLC ($99K).
What is the short interest in CODX?
656,373 shares were sold short at the 2026-10-15 settlement, 56.68% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.